Gene Synthesis Market to Observe Significant Growth by 2031 Due to Strategic Partnerships and Technological Advancements by Market Players, such as Raaka, Cargill, and Others

Gene synthesis is swiftly revolutionizing biomedical research. Gene synthesis services are significantly turning out to be a key part of current biological research processes. Gene synthesis, which is also called DNA synthesis, is the formation of gene-length double-stranded DNA fragments.

This technique is not new. The first gene was synthesized in 1970 as a part of an effort to decrypt a genetic code. Nevertheless, this technology has been accessible as a service from the year 2000. Today, gene synthesis is used to produce plasmids designed in computers, enhance gene expression, and in several other application areas.

Forecast Analysis of the Market

As per a report by Research Dive, the global gene synthesis market is expected to grow from $1,110,000 thousand in 2021 to $5,984,016.7 thousand by 2031. The market’s enormous growth is mostly owing to the mounting applications of gene synthesis in the healthcare sector. Additionally, in recombinant DNA technology, gene synthesis is extensively accepted tool that comprises recombinant protein production.

Moreover, the rising demand for gene synthesis amongst the population with genetic and chronic disorders across the globe and rising investments in the synthetic biology by government organizations and private & public companies are the factors predicted to hasten the global gene synthesis market growth. This is going to pave way for lucrative opportunities for the leading companies functioning in the market in the forthcoming years.

Gene Synthesis Market Trends and Developments

Market players are considerably investing in research and development to cater the mounting demand for gene synthesis in research activities. Some of the leading players of the gene synthesis market are Brooks Automation, Inc. (GENEWIZ), Twist Bioscience, Codex DNA, Biomatik, ProMab Biotechnologies, Inc., Boster Biological Technology, Integrated DNA Technologies, Inc., GenScript, OriGene Technologies, Inc., Thermo Fisher Scientific, Inc., and others. These players are concentrated on developing strategies, such as mergers and acquisitions, partnerships, novel developments, and collaborations to achieve a prominent position in the global market. For instance:

• In June 2019, GenScript, the global leader in offering gene synthesis services, introduced a substantial upgrade to its GenBrick™ Gene Synthesis platform, bringing scientists access to DNA sequences up to 200kb long with 100% precision.
   
• In November 2021, Codex DNA, Inc. (now Telesis Bio), a synthetic biology company focused on the development of automation solutions for DNA, RNA, and protein synthesis, announced the commercial availability of automated mRNA synthesis kit with integrated capping technology for BioXp™ system.
• In January 2023, Moderna, Inc., a biotechnology company pioneering mRNA therapeutics and vaccines, entered into a definitive agreement with OriCiro Genomics, a forerunner in cell-free DNA synthesis and amplification technologies, to acquire OriCiro for $85 million. With this acquisition, Moderna will obtain best-in-class tools for cell-free synthesis and amplification of plasmid DNA.

COVID-19 Impact on the Gene Synthesis Market

The abrupt rise of the coronavirus pandemic has both positively and negatively impacted the global gene synthesis market. This is mainly due to the rising usage of gene synthesis in scientific research activities. For instance, in 2020, the National Institute of Standards and Technology (NIST), unveiled that they have formed artificial gene fragments from the COVID-19 virus. The use of gene synthesis in such developments is greatly contributing to the market growth. Moreover, as the worldwide economy is recovering with the relaxation of pandemic, the use of gene synthesis in medical research projects is gaining traction. This is likely to boom the gene synthesis market in the imminent years.

Most Profitable Region

The gene synthesis market in the North America region is expected to be most dominant during the forecast period. This is mainly owing to the increasing rate of chronic diseases and higher gene therapy in the region. Besides, the expansion of research and development on new gene-based technologies and the availability of experienced researchers in the countries like the US and Canada, are the factors further anticipated to drive the regional market growth.